Company: ACTG
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000934549-25-000054
Chunk: 54

Company: ACACIA RESEARCH CORP
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 54
---
— $— Exercised(8,333)$3.58 $3 Forfeited/Expired— $— $— Outstanding at September 30, 2025993,187 $4.16 $— 6.6 yearsExercisable at September 30, 2025834,208 $4.19 $— 6.5 yearsVested and expected to vest at September 30, 2025993,187 $4.16 $— 6.6 yearsUnrecognized stock-based compensation expense at September 30, 2025 (in thousands)$91 Weighted average remaining vesting period at September 30, 20250.5 yearsDuring the three and nine months ended September 30, 2025, there were no stock options granted. The aggregate fair value of options vested during the nine months ended September 30, 2025 was $420,000.

36

The following table summarizes nonvested restricted stock activity for the Plans:RSAsRSUsPSUsSharesWeighted Average Grant Date Fair ValueUnitsWeighted Average Grant Date Fair ValueUnitsWeighted Average Grant Date Fair ValueNonvested at December 31, 202467,668 $3.63 833,195 $4.42 1,981,464 $4.61 Granted56,162 $3.56 193,032 $3.73 — $— Vested(123,830)$3.60 (521,041)$4.46 — $— Forfeited— $— — $— — $— Nonvested at September 30, 2025— $— 505,186 $4.11 1,981,464 $4.61 Unrecognized stock-based compensation expense at September 30, 2025 (in thousands)$— $1,238 $911 Weighted average remaining vesting period at September 30, 2025— 0.6 years0.7 yearsRSAs and RSUs granted are time-based and will vest in full after one to three years. The aggregate fair value of RSAs vested during the nine months ended September 30, 2025 was $446,000. The aggregate fair value of RSUs vested during the nine months ended September 30, 2025 was $2.